BioInvent International
BioInvent: New Orphan Drug Designation in Lymphoma (Redeye)
2022-01-19 12:33
Redeye views the orphan drug designation for BI-1206 in follicular lymphoma as a further confirmation of being on the right path in lymphoma.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se